{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:57:53Z","timestamp":1776992273342,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1023\/a:1007878523663","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T21:55:50Z","timestamp":1041112550000},"page":"271-281","source":"Crossref","is-referenced-by-count":23,"title":["Effect of a Calcium-Sensitizing Agent, Levosimendan, on the Postcardioplegic Inotropic Response of the Myocardium"],"prefix":"10.1007","volume":"14","author":[{"given":"A.","family":"Lochner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Colesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Genade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"260144_CR1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/bmj.284.6309.104","volume":"284","author":"RH Robson","year":"1982","unstructured":"Robson RH, Vishwanath MC. Nifedipine and \u03b2-blockade as a cause of cardiac failure. Br Med J 1982;284:104.","journal-title":"Br Med J"},{"key":"260144_CR2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.65.4.660","volume":"65","author":"MP Packer","year":"1982","unstructured":"Packer MP, Meller J, Medina N, et al. Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation 1982;65:660-668.","journal-title":"Circulation"},{"key":"260144_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198903163201107","volume":"320","author":"MP. Packer","year":"1989","unstructured":"Packer MP. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989;320:709-718.","journal-title":"N Engl J Med"},{"issue":"Suppl.VI","key":"260144_CR4","first-page":"VI17","volume":"80","author":"E Marban","year":"1989","unstructured":"Marban E, Koretsune Y, Corretti M. Calcium and its role in myocardial injury during ischaemia and reperfusion. Circulation 1989;80(Suppl. VI):VI17-VI22.","journal-title":"Circulation"},{"key":"260144_CR5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.RES.70.5.960","volume":"70","author":"EF Du Toit","year":"1992","unstructured":"Du Toit EF, Opie LH. Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 1992;70: 960-967.","journal-title":"Circ Res"},{"key":"260144_CR6","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/0022-2828(95)90009-8","volume":"27","author":"H Haikala","year":"1995","unstructured":"Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki J, Linden I-B. Cardiac troponin-C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995;27:1859-1866.","journal-title":"J Mol Cell Cardiol"},{"key":"260144_CR7","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00005344-199505000-00016","volume":"25","author":"H Haikala","year":"1995","unstructured":"Haikala H, Nissinen E, Etemadzadek E, Levijoki J, Linden I-B. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 1995;25:794-801.","journal-title":"J Cardiovasc Pharmacol"},{"key":"260144_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.RES.77.1.107","volume":"77","author":"I Edes","year":"1995","unstructured":"Edes I, Kiss E, Kitada Y, et al. Effect of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and calcium sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res 1995;77:107-113.","journal-title":"Circ Res"},{"key":"260144_CR9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(97)01362-9","volume":"339","author":"MK Lancaster","year":"1997","unstructured":"Lancaster MK, Cook SJ. The effects of levosimendan on (Ca2+)i in guinea pig isolated ventricular myocytes. Eur J Pharmacol 1997;339:97-100.","journal-title":"Eur J Pharmacol"},{"key":"260144_CR10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(24)36997-6","volume":"283","author":"H Yokoshiki","year":"1997","unstructured":"Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. The novel calcium sensitizer levosimendan activates the ATP-sensitive K+ channel in rat ventricular cells. J Pharmacol Exp Ther 1997;283:375-383.","journal-title":"J Pharmacol Exp Ther"},{"key":"260144_CR11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00005344-199805000-00013","volume":"31","author":"N Gruhn","year":"1998","unstructured":"Gruhn N, Nielsen-Kudsk JE, Theilgaard S, Bang L, Olesen SP, Aldershvile J. Coronary vasorelaxant effect of levosimendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998;31:741-749.","journal-title":"J Cardiovasc Pharmacol"},{"key":"260144_CR12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01108-4","volume":"333","author":"H Yokoshiki","year":"1997","unstructured":"Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N. Levosimendan, a novel Ca2+-sensitizer, activates the glibenclamide-sensitiveK+ channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249-259.","journal-title":"Eur J Pharmacol"},{"key":"260144_CR13","first-page":"23","volume":"85","author":"IN Jamali","year":"1997","unstructured":"Jamali IN, Kersten JR, Pagel PS, Hettrick DA, Warltier DC. Intracoronary levosimendan enhances contractile function of stunned myocardium. Anesth Analg 1997;85:23-29.","journal-title":"Anesth Analg"},{"key":"260144_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0022-2828(79)90464-4","volume":"11","author":"GJ Kannengieser","year":"1979","unstructured":"Kannengieser GJ, Opie LH, Van der Werff TJ. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischaemic myocardium. J Mol Cell Cardiol 1979;11:197-207.","journal-title":"J Mol Cell Cardiol"},{"key":"260144_CR15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/BF00877715","volume":"7","author":"P Hattingh","year":"1993","unstructured":"Hattingh P, Coetzee A, Harper I, Genade S, Lochner A. Effects of beta-blockers and Ca2+-antagonists on the response of the isolated working rat heart to adrenergic stimulants after cardioplegic arrest. Cardiovasc Drugs Ther 1993;7:851-861.","journal-title":"Cardiovasc Drugs Ther"},{"key":"260144_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-3565(24)36368-2","volume":"280","author":"P Boknik","year":"1997","unstructured":"Boknik P, Neumann J, Kaspareit G, et al. Mechanisms of the contractile effects of levosimendan in the mammalian heart. J Pharmacol Exp Therap 1997;280:277-283.","journal-title":"J Pharmacol Exp Therap"},{"key":"260144_CR17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1006\/jmcc.1998.0677","volume":"30","author":"S Sato","year":"1998","unstructured":"Sato S, Talukder MA, Sugawara H, Sawada H, Endoh M. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and Indo-1-loaded single ventricular cardiomyocytes of the rabbit. J Mol Cell Cardiol 1998;30:1115-1128.","journal-title":"J Mol Cell Cardiol"},{"key":"260144_CR18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1113\/jphysiol.1994.sp020038","volume":"474","author":"D DiFrancesco","year":"1994","unstructured":"DiFrancesco D, Mangoni M. Modulation of single hyperpolarization-activated channels (if) by cAMP in rabbit sino-atrial node. J Physiol 1994;474:473-482.","journal-title":"J Physiol"},{"key":"260144_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00005344-199508000-00002","volume":"26","author":"CP Harkin","year":"1995","unstructured":"Harkin CP, Pagel PS, Tessmer JP, Warltier DC. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. J Cardiovasc Pharmacol 1995;26:179-188.","journal-title":"J Cardiovasc Pharmacol"},{"key":"260144_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)12026-0","volume":"275","author":"PS Pagel","year":"1995","unstructured":"Pagel PS, Harkin CP, Hettrick DA, Warltier DC. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs. J Pharmacol Exp Ther 1995;275:127-135.","journal-title":"J Pharmacol Exp Ther"},{"key":"260144_CR21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-3565(24)37957-1","volume":"288","author":"P Bowman","year":"1999","unstructured":"Bowman P, Haikala H, Paul RJ. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. J Pharmacol Exp Ther 1999;288:316-325.","journal-title":"J Pharmacol Exp Ther"},{"key":"260144_CR22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.90.2.959","volume":"90","author":"LK Soei","year":"1994","unstructured":"Soei LK, Sassen LMA, Fan DS. Myofibrillar Ca2+ sensitization predominantly enhances function and mechanical efficiency of stunned myocardium. Circulation 1994;90:959-969.","journal-title":"Circulation"},{"key":"260144_CR23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/euhj.1997.0806","volume":"19","author":"J Lilleberg","year":"1998","unstructured":"Lilleberg J, Nieminen MS, Akkila J, et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998;19:660-668.","journal-title":"Eur Heart J"},{"key":"260144_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000542-198902000-00002","volume":"70","author":"S Slogoff","year":"1989","unstructured":"Slogoff S, Keats AS. Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 1989;70:179-188.","journal-title":"Anesthesiology"},{"key":"260144_CR25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(80)90064-8","volume":"46","author":"WG Nayler","year":"1980","unstructured":"Nayler WG, Ferrari R, Williams A. Protective effect of pretreatment with verapamil, nifedipine and propranolol on myocardial function in the ischaemic and reperfused myocardium. Am J Cardiol 1980;46:242-248.","journal-title":"Am J Cardiol"},{"key":"260144_CR26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.63.1.262","volume":"63","author":"IT Mak","year":"1988","unstructured":"Mak IT, Weglicki WB. Protection by \u03b2-blocking agents against free radical-mediated sarcolemmal lipid peroxidation. Circ Res 1988;63:262-266.","journal-title":"Circ Res"},{"key":"260144_CR27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/01.RES.66.5.1449","volume":"66","author":"IT Mak","year":"1990","unstructured":"Mak IT, Weglicki WB. Comparative anti-oxidant activities of propranolol, nifedipine, verapamil and diltiazem against sarcolemmal membrane lipid peroxidation. Circ Res 1990;66:1449-1452.","journal-title":"Circ Res"},{"key":"260144_CR28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3565(24)34928-6","volume":"290","author":"EF Du Toit","year":"1999","unstructured":"Du Toit EF, Muller CA, McCarthy J, Opie LH. Levosimendan: Effects of a calcium sensitizer on function and cyclic nucleotide levels during ischemia\/reperfusion in the Langendorff perfused guinea pig heart. J Pharmacol Exp Ther 1999;290:505-514.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007878523663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007878523663\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007878523663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:24:17Z","timestamp":1751052257000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007878523663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["260144"],"URL":"https:\/\/doi.org\/10.1023\/a:1007878523663","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}